BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9748143)

  • 21. Creation and characterization of 5-fluorodeoxyuridine-resistant Arg50 loop mutants of human thymidylate synthase.
    Landis DM; Heindel CC; Loeb LA
    Cancer Res; 2001 Jan; 61(2):666-72. PubMed ID: 11212266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells.
    Takagi K; Sowa Y; Cevik OM; Nakanishi R; Sakai T
    Int J Oncol; 2008 May; 32(5):1105-10. PubMed ID: 18425338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer.
    Ishida Y; Kawakami K; Tanaka Y; Kanehira E; Omura K; Watanabe G
    Anticancer Res; 2002; 22(5):2805-9. PubMed ID: 12530000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-fluoro-2'-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells.
    Parsels LA; Parsels JD; Tai DC; Coughlin DJ; Maybaum J
    Cancer Res; 2004 Sep; 64(18):6588-94. PubMed ID: 15374972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repression of human thymidylate synthase mRNA translation by antisense 2'-O-methyl oligoribonucleotides.
    Schmitz JC; Agrawal S; Chu E
    Antisense Nucleic Acid Drug Dev; 1998 Oct; 8(5):371-8. PubMed ID: 9826264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
    Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH
    Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining small interfering RNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5-fluorodeoxyuridine and pemetrexed.
    Di Cresce C; Figueredo R; Ferguson PJ; Vincent MD; Koropatnick J
    J Pharmacol Exp Ther; 2011 Sep; 338(3):952-63. PubMed ID: 21673071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retroviral coexpression of thymidylate synthase and dihydrofolate reductase confers fluoropyrimidine and antifolate resistance.
    Fantz CR; Shaw D; Moore JG; Spencer HT
    Biochem Biophys Res Commun; 1998 Feb; 243(1):6-12. PubMed ID: 9473470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism of the thymidylate synthase gene and thymidylate synthase levels in colon cancer cell lines and different tissues of colorectal cancer patients.
    Mauritz R; Beumer IJ; Marsh S; McLeod HL; Smid K; van Groeningen CJ; Pinedo HM; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1381-4. PubMed ID: 15571263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2'-deoxyuridine in mammalian and bacterial cells.
    Barbour KW; Hoganson DK; Berger SH; Berger FG
    Mol Pharmacol; 1992 Aug; 42(2):242-8. PubMed ID: 1355260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of transforming growth factor beta (TGFbeta1) expression and extracellular matrix secretion in human peritoneal mesothelial cells by pcDU6 vector-mediated TGFbeta1 shRNA and by pcDNA3.1(-)-mediated antisense TGFbeta1 RNA.
    Liu F; Liu H; Peng Y; Yuan F; Liu Y; Duan S
    Adv Perit Dial; 2005; 21():41-52. PubMed ID: 16686283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-mRNA processing enhancer (PPE) element increases the expression of an intronless thymidylate synthase gene but does not affect intron-dependent S phase regulation.
    Lee TX; Johnson LF
    J Cell Biochem; 1998 May; 69(2):104-16. PubMed ID: 9548559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test.
    Kakimoto M; Uetake H; Osanai T; Shirota Y; Takagi Y; Takeshita E; Toriya Y; Danenberg K; Danenberg PV; Sugihara K
    Cancer Lett; 2005 Jun; 223(1):103-11. PubMed ID: 15890242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition.
    Koehler SE; Ladner RD
    Mol Pharmacol; 2004 Sep; 66(3):620-6. PubMed ID: 15322254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations between thymidylate synthase expression and chemosensitivity to 5-fluorouracil, cell proliferation and clinical outcome in head and neck squamous cell carcinoma.
    Yasumatsu R; Nakashima T; Uryu H; Ayada T; Wakasaki T; Kogo R; Masuda M; Fukushima M; Komune S
    Chemotherapy; 2009; 55(1):36-41. PubMed ID: 19023200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions.
    Peters GJ; Smitskamp-Wilms E; Smid K; Pinedo HM; Jansen G
    Cancer Res; 1999 Nov; 59(21):5529-35. PubMed ID: 10554030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy.
    Brody JR; Hucl T; Gallmeier E; Winter JM; Kern SE; Murphy KM
    Cancer Res; 2006 Oct; 66(19):9369-73. PubMed ID: 17018589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene.
    Yang Z; Cloud A; Hughes D; Johnson LF
    Cancer Gene Ther; 2006 Jan; 13(1):107-14. PubMed ID: 16052228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines.
    Jason TL; Figueredo R; Ferguson PJ; Vincent MD; Berg RW; Koropatnick J
    DNA Cell Biol; 2008 May; 27(5):229-40. PubMed ID: 18358073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.